CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Shares withheld for taxes Director gave up 2,735 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 2,735 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Director gave up 1,339 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,339 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,339 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,339 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,339 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,339 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 2,901 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Director and CEO, Alkermes plc gave up 36,267 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 4,608 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Corp Dev., Alkermes, Inc. gave up 3,566 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 2,024 shares (to pay taxes)
- 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 5,647 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CLO, Alkermes, Inc. gave up 4,634 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 3,057 shares (to pay taxes)
- 4 Open-market buy Director bought 1,650.17 shares at $30.22 ($49,860)
- 4 Open-market sale SVP, Chief Financial Officer sold 40,000 shares at $29.99 ($1,199,600)
Page 15 of 67 · 1,323 filings